- Cancer research
- Career spotlights
- Customer stories
- Gene editing
- Single-cell analysis
- Stem cell research
- Tips and troubleshooting
- ICYMI: 2018 blog posts
- About our blog
The fight against cancer remains an uphill battle. However, ongoing advances in cancer biomarker discovery, immunotherapy, single cell analysis, drug discovery, etc., offer great hope in the fight against cancer. Through our posts, we strive to keep you updated on the latest news, tools, publications, and therapy options in the field of cancer research.
Date: July 10, 2019
Discover how PrimeSTAR GXL helped in the identification of intragenic deletions in the Epstein-Barr virus genome associated with lymphomagenesis.
Learn more about how our Titanium Taq provided robust and sensitive amplification in breast cancer research.
Learn how CAR T-cell therapies are making cancer treatment targeted, safer, and better.
Date: January 1, 2019
A novel protocol that enables the detection of both SNVs and CNVs from 1-5 cells in a single, low-pass sequencing run that saves time and money.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2019 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.